These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20354765)

  • 1. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs.
    Harvey AJ; Kaestner SA; Sutter DE; Harvey NG; Mikszta JA; Pettis RJ
    Pharm Res; 2011 Jan; 28(1):107-16. PubMed ID: 20354765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear.
    Rini CJ; McVey E; Sutter D; Keith S; Kurth HJ; Nosek L; Kapitza C; Rebrin K; Hirsch L; Pettis RJ
    Drug Deliv Transl Res; 2015 Aug; 5(4):332-45. PubMed ID: 26037035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid intradermal delivery of liquid formulations using a hollow microstructured array.
    Burton SA; Ng CY; Simmers R; Moeckly C; Brandwein D; Gilbert T; Johnson N; Brown K; Alston T; Prochnow G; Siebenaler K; Hansen K
    Pharm Res; 2011 Jan; 28(1):31-40. PubMed ID: 20582455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection.
    Pettis RJ; Ginsberg B; Hirsch L; Sutter D; Keith S; McVey E; Harvey NG; Hompesch M; Nosek L; Kapitza C; Heinemann L
    Diabetes Technol Ther; 2011 Apr; 13(4):435-42. PubMed ID: 21355718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats.
    Fukushima K; Ise A; Morita H; Hasegawa R; Ito Y; Sugioka N; Takada K
    Pharm Res; 2011 Jan; 28(1):7-21. PubMed ID: 20300802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
    Pettis RJ; Hirsch L; Kapitza C; Nosek L; Hövelmann U; Kurth HJ; Sutter DE; Harvey NG; Heinemann L
    Diabetes Technol Ther; 2011 Apr; 13(4):443-50. PubMed ID: 21355716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique.
    Donnelly RF; Majithiya R; Singh TR; Morrow DI; Garland MJ; Demir YK; Migalska K; Ryan E; Gillen D; Scott CJ; Woolfson AD
    Pharm Res; 2011 Jan; 28(1):41-57. PubMed ID: 20490627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioceramic microneedles with flexible and self-swelling substrate.
    Cai B; Xia W; Bredenberg S; Li H; Engqvist H
    Eur J Pharm Biopharm; 2015 Aug; 94():404-10. PubMed ID: 26126420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration.
    Nordquist L; Roxhed N; Griss P; Stemme G
    Pharm Res; 2007 Jul; 24(7):1381-8. PubMed ID: 17387600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coating formulations for microneedles.
    Gill HS; Prausnitz MR
    Pharm Res; 2007 Jul; 24(7):1369-80. PubMed ID: 17385011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedles for drug delivery via the gastrointestinal tract.
    Traverso G; Schoellhammer CM; Schroeder A; Maa R; Lauwers GY; Polat BE; Anderson DG; Blankschtein D; Langer R
    J Pharm Sci; 2015 Feb; 104(2):362-7. PubMed ID: 25250829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis.
    Daddona PE; Matriano JA; Mandema J; Maa YF
    Pharm Res; 2011 Jan; 28(1):159-65. PubMed ID: 20567999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography.
    Coulman SA; Birchall JC; Alex A; Pearton M; Hofer B; O'Mahony C; Drexler W; Považay B
    Pharm Res; 2011 Jan; 28(1):66-81. PubMed ID: 20464461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Intradermal Administration Volume Using a Hollow Microneedle on the Pharmacokinetics of Fluorescein Isothiocyanate Dextran (M.W. 4,000).
    Futaki M; Inamura K; Hashimoto M; Motegi S; Itakura S; Sugibayashi K; Todo H
    Pharm Res; 2023 Aug; 40(8):1953-1963. PubMed ID: 37165148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Troy Microneedle: A Rapidly Separating, Dissolving Microneedle Formed by Cyclic Contact and Drying on the Pillar (CCDP).
    Kim M; Yang H; Kim S; Lee C; Jung H
    PLoS One; 2015; 10(8):e0136513. PubMed ID: 26308945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced bioavailability of L-carnitine after painless intradermal delivery vs. oral administration in rats.
    Zhang S; Qin G; Wu Y; Gao Y; Qiu Y; Li F; Xu B
    Pharm Res; 2011 Jan; 28(1):117-23. PubMed ID: 20387100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
    Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
    Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
    McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.